Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases
This article is protected by copyright. All rights reserved.
Source: Acta Physiologica - Category: Physiology Authors: Anita T. Layton, Volker Vallon Tags: Editorial Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Physiology | SGLT2 Inhibitors | Urology & Nephrology